Showing 11-20 of 84 results for "".
Recent Developments
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recent-developments-41/23828/Consuming grapes can protect against ultraviolet (UV) damage to the skin, according to a new study in Antioxidants. Study participants showed increased resistance to sunburn after consuming 2.25 cups of grapes every day for 2 weeks. Additionally, subjects displaying UV resistance demonstrated uniqueRecent Developments
https://practicaldermatology.com/columns/recent-developments/the-game-of-drones/23021/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-35/23723/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20371/Meet the CSF Faculty
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/meet-the-csf-faculty/23824/Get to know Dr. Todd SchlesingerRevealed: The Two Hottest New Skin Cancer Ingredients
https://practicaldermatology.com/conferences/scale-2023/revealed-the-two-hottest-new-skin-cancer-ingredients/20202/Todd Schlesinger, MD, discusses the growing role of exosomes and cannabidiol (CBD) in dermatology.Build Leadership Skills in Staff Members
https://practicaldermatology.com/topics/practice-management/build-leadership-skills-in-staff-members/19110/Todd E. Schlesinger, MD discusses strategies for cultivating leadership among staff and highlights the importance of positioning staff to succeed.Implementing and Growing PDT
https://practicaldermatology.com/series/pdt-in-practice/implementing-and-growing-pdt/29783/Dr. Todd Schlesinger described how he implemented photodynamic therapy in his practice and the strategies he utilized to increase patient access to it.The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Managing Advanced Skin Cancers
https://practicaldermatology.com/conferences/aad-2021/managing-advanced-skin-cancers/19920/Treatment of advanced NMSC can be a challenge, but therapeutic options continue to expand. Todd Schlesinger, MD discusses real-world use of hedgehog inhibitors—including modified regimens and adjuvant use—and PD-1 inhibitors for advanced disease.